肝细胞癌的影像特征:钆塞酸二钠增强MRI与钆喷酸葡胺增强MRI的定量与定性比较
本研究比较了肝细胞癌在Gd-EOB-DTPA(EOB)与细胞外对比剂(ECA;Gd-DTPA)增强MRI上的主要影像特征。按肿瘤大小、Edmonson分级和肉眼类型匹配55个肝细胞癌后,定性分析显示EOB在延迟/移行期低信号更常见、包膜表现更少;定量分析显示ECA在动脉期病肝对比度更好、EOB在延迟期病肝对比度更好。
要点
- EOB增强MRI延迟/移行期低信号较ECA更常见(91% vs 73%,P=0.026)。
- EOB增强MRI包膜表现较ECA更少见(31% vs 73%,P<0.001)。
- 动脉期病肝对比度ECA优于EOB(P=0.003),延迟期病肝对比度EOB优于ECA(P<0.001)。
核心结论
- ECA-MRI在动脉期病肝对比度和包膜表现检出率方面优于EOB-MRI,而EOB-MRI在移行期病肝对比度方面更优。
研究设计与样本
- 回顾性匹配分析,184个经手术证实的肝细胞癌(169例患者)中,接受EOB增强MRI者120个病灶、ECA增强MRI者49个病灶,按肿瘤大小、Edmonson分级(主要与最差)和肉眼类型匹配后每组各55个病灶;由2名委员会认证放射科医师独立定性分析,第3名放射科医师定量测量信号强度。
关键影像表现/征象
- EOB组延迟/移行期低信号出现率 reader 1 为91%、reader 2 为89%,ECA组 reader 1 为73%、reader 2 为75%(P=0.026)。
- EOB组包膜表现出现率 reader 1 为31%、reader 2 为44%,ECA组 reader 1 为73%、reader 2 为78%(P<0.001)。
诊断标准与关键数值
- 定性分析评估动脉期高强化、门静脉期低信号、延迟或移行期(120-150秒)低信号及包膜表现。
- 定量分析计算病肝对比度(LLC)和病肝对比度增强比(LLCER),分别在动脉期、门静脉期和延迟期测量。
临床应用与阅片要点
- 判读肝细胞癌包膜表现时,需注意EOB增强MRI上包膜显示率低于ECA增强MRI。
- 评估动脉期强化特征时,ECA增强MRI的病肝对比度优于EOB增强MRI。
- 评估延迟/移行期低信号时,EOB增强MRI的病肝对比度及低信号显示率优于ECA增强MRI。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to compare the major imaging features of hepatocellular carcinoma (HCC) on magnetic resonance imaging (MRI) scans with Gd-EOB-DTPA (EOB) and extracellular agent (ECA; Gd-DTPA) contrast media.
MATERIALS AND METHODS: Among 184 surgically proven HCCs in 169 patients who underwent a liver MRI with either EOB (n = 120) or ECA (n = 49), 55 HCCs were matched according to tumor size, Edmonson grade (major and worst), and gross type for each of the 2 contrast media. For the qualitative analysis, 2 board-certified radiologists independently reviewed arterial phase hyperenhancement, hypointensity on portal venous phase, hypointensity on delayed or transitional phase (DP/TP, 120-150 seconds), and capsule appearance. For the quantitative analysis, a third radiologist measured the signal intensity at each phase by placing the region of interest for tumor and normal liver parenchyma. The lesion-to-liver contrast (LLC) and lesion-to-liver contrast enhancement ratio (LLCER) were calculated.
RESULTS: On qualitative analysis, hypointensity on DP/TP was seen more frequently with EOB (91% in reader 1, 89% in reader 2) than with ECA (73% in reader 1, 75% in reader 2; P = 0.026). Capsule appearance was seen less frequently with EOB (31% in reader 1, 44% in reader 2) than with ECA (73% in reader 1, 78% in reader 2; P < 0.001). On quantitative analysis, the LLC on arterial phase (AP) was better with ECA (P = 0.003), whereas LLC on DP was better with EOB (P < 0.001). The LLCER from precontrast to AP was higher with ECA (P = 0.022), whereas the LLCER from portal venous phase to DP was higher with EOB (P < 0.001).
CONCLUSIONS: ECA-MRI revealed better LLC on AP and detection rate of capsule appearance than EOB-MRI. EOB-MRI showed superior LLC on TP.
引用
- Son J, Hwang SH, Park S, et al. Imaging Features of Hepatocellular Carcinoma: Quantitative and Qualitative Comparison Between MRI-Enhanced With Gd-EOB-DTPA and Gd-DTPA. Invest Radiol. 2019. PMID: 31094878. doi:10.1097/RLI.0000000000000562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。